1 / 3

Autoimmune Disorder Drug Delivery Devices Market

The global market for autoimmune disorder drug delivery devices is predicted to grow at a CAGR of 15.25% over the forecast period of 2020-2030. The market is driven by certain factors, including the increasing global geriatric population, increasing incidence of chronic diseases including autoimmune disorders, and rise in demand for self-injectable systems.<br>

bisreports
Download Presentation

Autoimmune Disorder Drug Delivery Devices Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Autoimmune Disorder Drug Delivery Devices The shifting trend toward increased use and adoption of biologics and biosimilar drugs, especially monoclonal antibodies had led to the demand for better injectable drug delivery devices.

  2. Global Autoimmune Disorder Drug Delivery Devices Market, $Million, 2019 -2030 10,686.5 Owing to the growing geriatric population, the rising prevalence of autoimmune disorders, and the increasing shift toward home healthcare in the Asia-Pacific region, the demand for autoimmune disorder drug delivery devices is expected to witness a high CAGR of 17.32% in the forecast period. $Million 10,000 CAGR 15.25% 8,000 1,685.2 6,500 4,000 2,000 0 2019 2030 Source: Expert Interviews and BIS Analysis. *To access the full research report, please follow the link- https://bisresearch.com/industry-report/autoimmune-disorder-drug-delivery-devices-market.html

  3. Market Growth Drivers and Opportunities Short Term Impact (1-2 Years) Long Term Impact (8-10 Years) Increased Prevalence of Autoimmune Disorders Technological Advancement in the Field of Pre-Filled Syringes Rising Geriatric Population Surge Pharmaceutical Market of Biosimilars and Biologics in the HIGH Device Connectivity to Ease the Competitive Pressure MEDIUM

More Related